Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2209 ARTÍCULOS , VIENDO DEL 586 AL 600

Animal models of the sporadic form of Alzheimer's disease: focus on the disease and not just the lesions

Iqbal K, Bolognin S, Wang X, Basurto-Islas G, Blanchard J, Tung YC.

J Alzheimers Dis. 2013;37(3):469-74. doi: 10.3233/JAD-130827.

Association between Alzheimer's disease and the NOS3 gene Glu298Asp polymorphism

Hua Y, Zhao H, Kong Y, Lu X.

Int J Neurosci. 2014 Apr;124(4):243-51. doi: 10.3109/00207454.2013.834336. Epub 2013 Sep 23.

Immunological functioning in Alzheimer's disease: differential effects of relative left versus right temporoparietal dysfunction

Foster PS, Roosa KM, Williams MR, Witt JC, Heilman KM, Drago V.

J Neuroimmunol. 2013 Oct 15;263(1-2):128-32. doi: 10.1016/j.jneuroim.2013.07.011. Epub 2013 Aug 15.

Meta-analysis on the association between the TF gene rs1049296 and AD

Wang Y, Xu S, Liu Z, Lai C, Xie Z, Zhao C, Wei Y, Bi JZ.

Can J Neurol Sci. 2013 Sep;40(5):691-7. doi: 10.1017/s0317167100014931.

Frequency power and coherence of electroencephalography are correlated with the severity of Alzheimer's disease: A multicenter analysis in Taiwan

Chen CC, Hsu CY, Chiu HW, Hu CJ, Lee TC.

J Formos Med Assoc. 2015 Aug;114(8):729-35. doi: 10.1016/j.jfma.2013.07.008. Epub 2013 Aug 19.

Slowing progression of early stages of AD with alternative therapies: a feasibility study

Lu DF, Hart LK, Lutgendorf SK, Oh H, Schilling M.

Geriatr Nurs. 2013 Nov-Dec;34(6):457-64. doi: 10.1016/j.gerinurse.2013.07.003. Epub 2013 Aug 22.

Dysfunctional synapse in Alzheimer's disease - A focus on NMDA receptors

Mota SI, Ferreira IL, Rego AC.

Neuropharmacology. 2014 Jan;76 Pt A:16-26. doi: 10.1016/j.neuropharm.2013.08.013. Epub 2013 Aug 22.

Genetics of Alzheimer's disease

Ridge PG, Ebbert MT, Kauwe JS.

Biomed Res Int. 2013;2013:254954. doi: 10.1155/2013/254954. Epub 2013 Jul 25.

Evaluation of common structural brain changes in aging and Alzheimer disease with the use of an MRI-based brain atrophy and lesion index: a comparison between T1WI and T2WI at 1.5T and 3T

Guo H, Song X, Vandorpe R, Zhang Y, Chen W, Zhang N, Schmidt MH, Rockwood K; Alzheimer's Disease Neuroimaging Initiative.

AJNR Am J Neuroradiol. 2014 Mar;35(3):504-12. doi: 10.3174/ajnr.A3709. Epub 2013 Aug 29.

Comparison of non-vertebral fracture between minodronate and risedronate therapy in elderly female patients with Alzheimer disease

Sato Y, Honda Y, Iwamoto J, Amano N.

J Musculoskelet Neuronal Interact. 2013 Sep;13(3):346-52.

Positive and negative effects of prostaglandins in Alzheimer's disease

Fattahi MJ, Mirshafiey A.

Psychiatry Clin Neurosci. 2014 Jan;68(1):50-60. doi: 10.1111/pcn.12092. Epub 2013 Sep 2.

[Alzheimer's disease and geriatric eye diseases in the aspect of amyloid genesis]

Ermilov VV, Tiurenkov IN, Nesterova AA, Zagrebin VA.

Arkh Patol. 2013 Mar-Apr;75(2):37-42.

Alzheimer's disease in the human eye. Clinical tests that identify ocular and visual information processing deficit as biomarkers

Chang LY, Lowe J, Ardiles A, Lim J, Grey AC, Robertson K, Danesh-Meyer H, Palacios AG, Acosta ML.

Alzheimers Dement. 2014 Mar;10(2):251-61. doi: 10.1016/j.jalz.2013.06.004. Epub 2013 Sep 5.

Preclinical trials in autosomal dominant AD: implementation of the DIAN-TU trial

Mills SM, Mallmann J, Santacruz AM, Fuqua A, Carril M, Aisen PS, Althage MC, Belyew S, Benzinger TL, Brooks WS, Buckles VD, Cairns NJ, Clifford D, Danek A, Fagan AM, Farlow M, Fox N, Ghetti B, Goate AM, Heinrichs D, Hornbeck R, Jack C, Jucker M, Klunk WE, Marcus DS, Martins RN, Masters CM, Mayeux R, McDade E, Morris JC, Oliver A, Ringman JM, Rossor MN, Salloway S, Schofield PR, Snider J, Snyder P, Sperling RA, Stewart C, Thomas RG, Xiong C, Bateman RJ.

Rev Neurol (Paris). 2013 Oct;169(10):737-43. doi: 10.1016/j.neurol.2013.07.017. Epub 2013 Sep 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias